OmniAb to Report Second Quarter 2024 Financial Results on August 8

OABI Stock  USD 3.52  0.07  1.95%   
Under 68% of OmniAb's investor base is looking to short. The analysis of the overall investor sentiment regarding OmniAb Inc suggests that many traders are alarmed. OmniAb's investing sentiment shows overall attitude of investors towards OmniAb Inc.
  
OmniAb, Inc. will report financial results for the three and six months ended June 30, 2024 after the close of the U.S. financial marke

Read at businesswire.com
businesswire News
  

OmniAb Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards OmniAb can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

OmniAb Fundamental Analysis

We analyze OmniAb's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of OmniAb using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of OmniAb based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Shares Owned By Insiders

Shares Owned By Insiders Comparative Analysis

OmniAb is currently under evaluation in shares owned by insiders category among its peers. Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

OmniAb Inc Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with OmniAb stock to make a market-neutral strategy. Peer analysis of OmniAb could also be used in its relative valuation, which is a method of valuing OmniAb by comparing valuation metrics with similar companies.

Peers

OmniAb Related Equities

EWTXEdgewise Therapeutics   1.95   
0%
19.0%
VRNAVerona Pharma   1.81   
0%
17.0%
PMVPPmv Pharmaceuticals   1.42   
0%
13.0%
ACETAdicet Bio   1.38   
0%
13.0%
ITOSIteos Therapeutics   1.29   
0%
12.0%
KROSKeros Therapeutics   0.27   
0%
2.0%
IDYAIdeaya Biosciences   0.48   
4.0%
0%
ERASErasca   0.71   
6.0%
0%
IPSCCentury Therapeutics   0.93   
9.0%
0%
GLUEMonte Rosa   1.03   
10.0%
0%
OLMAOlema Pharmaceuticals   1.29   
12.0%
0%
CGEMCullinan Oncology   1.29   
12.0%
0%
LEGNLegend Biotech   1.30   
12.0%
0%
IKNAIkena Oncology   2.14   
21.0%
0%
VORVor Biopharma   3.17   
31.0%
0%
PASGPassage Bio   3.77   
37.0%
0%
BCABBioatla   10.16   
100.0%
0%

Complementary Tools for OmniAb Stock analysis

When running OmniAb's price analysis, check to measure OmniAb's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OmniAb is operating at the current time. Most of OmniAb's value examination focuses on studying past and present price action to predict the probability of OmniAb's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OmniAb's price. Additionally, you may evaluate how the addition of OmniAb to your portfolios can decrease your overall portfolio volatility.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum